Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease

Abstract

Our findings show that plasma visfatin levels are not altered in the early stages of NAFLD. However, it is inversely associated with TNF-α. These findings suggest a role for visfatin in protection against liver injury in this widespread disease.

References

Page 1

	Year	Citations
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge William T. Friedewald, Robert I. Levy, Donald S. Fredrickson Clinical Chemistry Lipid AnalysisHyperlipidemiaDirect ProcedureMetabolic SyndromeBody Composition	1972	32.1K
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David R. Matthews, J P Hosker, A. Rudenski, Diabetologia Insulin ResistanceObesityMetabolic SyndromeBody CompositionHealth Sciences	1985	31K
Diagnosis and Classification of Diabetes Mellitus Diabetes Care	2010	14K
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Enzo Bonora, Giovanni Targher, Maria Alberiche, Diabetes Care	2000	2.4K
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Babru Samal, Y. Sun, George Stearns, Molecular and Cellular Biology CytokineImmunogeneticsTranscriptional RegulationProtein ExpressionHuman Cell	1994	961
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties Alexander R. Moschen, Arthur Kaser, Barbara Enrich, The Journal of Immunology	2007	914
Plasma Visfatin Concentrations and Fat Depot–Specific mRNA Expression in Humans Janin Berndt, Nora Klöting, Susan Kralisch, Diabetes	2005	712
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin Cyrile Anne Curat, Valérie Wegner, Coralie Sengenès, Diabetologia ObesityMetabolic SyndromeInflammationMetabolic DisorderPhysiology	2006	686
Pre–B cell colony–enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis Song Jia, Yue Li, Jean Parodo, Journal of Clinical Investigation	2004	594

Page 1